Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Overview
Authors
Affiliations
The lifecycle of Leishmania, the causative agent of leishmaniasis, alternates between promastigote and amastigote stages inside the insect and vertebrate hosts, respectively. While pathogenic symptoms of leishmaniasis can vary widely, from benign cutaneous lesions to highly fatal visceral disease forms depending on the infective species, all Leishmania species reside inside host macrophages during the vertebrate stage of their lifecycle. Leishmania infectivity is therefore directly related to its ability to invade, survive and replicate within parasitophorous vacuoles (PVs) inside macrophages. Thus, assessing the parasite's ability to replicate intracellularly serves as a dependable method for determining virulence. Studying leishmaniasis development using animal models is time-consuming, tedious and often difficult, particularly with the pathogenically important visceral forms. We describe here a methodology to follow the intracellular development of Leishmania in bone marrow-derived macrophages (BMMs). Intracellular parasite numbers are determined at 24 h intervals for 72 - 96 h following infection. This method allows for a reliable determination of the effects of various genetic factors on Leishmania virulence. As an example, we show how a single allele deletion of the Leishmania Mitochondrial Iron Transporter gene (LMIT1) impairs the ability of the Leishmania amazonensis mutant strain LMIT1/ΔLmit1 to grow inside BMMs, reflecting a drastic reduction in virulence compared to wild-type. This assay also allows precise control of experimental conditions, which can be individually manipulated to analyze the influence of various factors (nutrients, reactive oxygen species, etc.) on the host-pathogen interaction. Therefore, the appropriate execution and quantification of BMM infection studies provide a non-invasive, rapid, economical, safe and reliable alternative to conventional animal model studies.
Iron chelators: as therapeutic agents in diseases.
Salimi Z, Afsharinasab M, Rostami M, Eshaghi Milasi Y, Mousavi Ezmareh S, Sakhaei F Ann Med Surg (Lond). 2024; 86(5):2759-2776.
PMID: 38694398 PMC: 11060230. DOI: 10.1097/MS9.0000000000001717.
Down the membrane hole: Ion channels in protozoan parasites.
Jimenez V, Mesones S PLoS Pathog. 2022; 18(12):e1011004.
PMID: 36580479 PMC: 9799330. DOI: 10.1371/journal.ppat.1011004.
Alshaweesh J, Nakamura R, Tanaka Y, Hayashishita M, Musa A, Kikuchi M Microbiol Spectr. 2022; 10(5):e0112622.
PMID: 36190414 PMC: 9603372. DOI: 10.1128/spectrum.01126-22.
Sarkar A, Andrews N, Laranjeira-Silva M Int J Parasitol. 2019; 49(6):423-427.
PMID: 30910463 PMC: 6527483. DOI: 10.1016/j.ijpara.2019.02.002.